[1]
|
GLOBOCAN 2012 v1.0 (2013) Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [database on the Internet]. International Agency for Research on Cancer. http://globocan.iarc.fr
|
[2]
|
Siegel, R., Ma, J., Zou, Z., et al. (2014) Cancer Statistics. CA: A Cancer Journal for Clinicians, 64, 9-29. http://dx.doi.org/10.3322/caac.21208
|
[3]
|
Pohl, H. and Welch, H.G. (2005) The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma Incidence. Journal of the National Cancer Institute, 97, 142-146. http://dx.doi.org/10.1093/jnci/dji024
|
[4]
|
Pohl, H., Sirovich, B. and Welch, H.G. (2010) Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak? Cancer Epidemiology, Biomarkers & Prevention, 19, 1468-1470. http://dx.doi.org/10.1158/1055-9965.EPI-10-0012
|
[5]
|
Thrift, A.P. and Whiteman, D.C. (2012) The Incidence of Esophageal Adenocarcinoma Continues to Rise: Analysis of Period and Birth Cohort Effects on Recent Trends. Annals of Oncology, 23, 3155-3162. http://dx.doi.org/10.1093/annonc/mds181
|
[6]
|
Vaughan, T.L. and Fitzgerald, R.C. (2015) Precision Prevention of Oesophageal Adenocarcinoma. Nature Reviews Gastroenterology & Hepatology, 12, 243-248. http://dx.doi.org/10.1038/nrgastro.2015.24
|
[7]
|
Engel, L.S., Chow, W.-H., Vaughan, T.L., et al. (2003) Population Attributable Risks of Esophageal and Gastric Cancers. Journal of the National Cancer Institute, 95, 1404-1413. http://dx.doi.org/10.1093/jnci/djg047
|
[8]
|
Pandeya, N., Olsen, C.M. and Whiteman, D.C. (2013) Sex Differences in the Proportion of Esophageal Squamous Cell Carcinoma Cases Attributable to Tobacco Smoking and Alcohol Consumption. Cancer Epidemiology, 37, 579-584.
|
[9]
|
Howlader, N., Noone, A., Krapcho, M., et al. (2014) SEER Cancer Statistics Review, 1975-2011. National Cancer Institute. Bethesda, MD. (Based on November 2013 SEER data submission, posted to the SEER web site, April 2014) http://seer.cancer.gov/csr/1975_2011/
|
[10]
|
Cook, M.B., Chow, W.H. and Devesa, S.S. (2009) Oesophageal Cancer Incidence in the United States by Race, Sex, and Histologic Type, 1977-2005. British Journal of Cancer, 101, 855-859. http://dx.doi.org/10.1038/sj.bjc.6605246
|
[11]
|
Dubecz, A., Gall, I., Solymosi, N., Schweigert, M., Peters, J.H., Feith, M. and Stein, H.J. (2012) Temporal Trends in Long-Term Survival and Cure Rates in Esophageal Cancer: A SEER Database Analysis. Journal of Thoracic Oncology, 7, 443-447. http://dx.doi.org/10.1097/jto.0b013e3182397751
|
[12]
|
Spechler, S.J. (2002) Clinical Practice. Barrett’s Esophagus. The New England Journal of Medicine, 346, 836-842. http://dx.doi.org/10.1056/NEJMcp012118
|
[13]
|
Ronkainen, J., Aro, P., Storskrubb, T., Johansson, S.E., Lind, T., Bolling-Sternevald, E., et al. (2005) Prevalence of Barrett’s Esophagus in the General Population: An Endoscopic Study. Gastroenterology, 129, 1825-1831. http://dx.doi.org/10.1053/j.gastro.2005.08.053
|
[14]
|
Kendall, B.J. and Whiteman, D.C. (2006) Temporal Changes in the Endoscopic Frequency of New Cases of Barrett’s Esophagus in an Australian Health Region. The American Journal of Gastroenterology, 101, 1178-1182. http://dx.doi.org/10.1111/j.1572-0241.2006.00548.x
|
[15]
|
Krishnan, K., Ruffin IV, M.T. and Brenner, D.E. (2000) Chemoprevention for Colorectal Cancer. Critical Reviews in Oncology/Hematology, 33, 199-219. http://dx.doi.org/10.1016/S1040-8428(99)00075-X
|
[16]
|
Shiff, J.S. and Rigas, B. (1997) Nonsteroidal Anti-Inflammatory Drugs and Colorectal Cancer: Evolving Concepts of Their Chemopreventive Actions. Gastroenterology, 113, 1992-1998. http://dx.doi.org/10.1016/S0016-5085(97)99999-6
|
[17]
|
Shiff, J.S. and Rigas, B. (1999) The Role of Cyclooxygenase Inhibition in the Antineoplastic Effects of Nonsteroidal Anti-Inflammatory Drugs. The Journal of Experimental Medicine, 190, 445-450. http://dx.doi.org/10.1084/jem.190.4.445
|
[18]
|
Hardman, J.G., Limbert, L.E., Molinoff, P.B., Ruddon, R.W. and Gilman, A.G., Eds. (1996) Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 9th Edition, McGraw-Hill, Inc., New York.
|
[19]
|
Bjorkman, D.J. (1999) Current Status of Nonsteroidal Anti-Inflammatory Drug (NSAID) Use in the United States: Risk Factors and Frequency of Complications. American Journal of Medicine, 107, 3S-8S.
|
[20]
|
Del Soldato, P., Sorrentino, R. and Pinto, A. (1999) NO-Aspirins: A Class of New Anti-Inflammatory and Antithrombotic Agents. Trends in Pharmacological Sciences, 20, 319-323. http://dx.doi.org/10.1016/S0165-6147(99)01353-X
|
[21]
|
Wolfe, M.M. (1998) Future Trends in the Development of Safer Nonsteroidal Anti-Inflammatory Drugs. American Journal of Medicine, 105, 44S-52S. http://dx.doi.org/10.1016/S0002-9343(98)00281-2
|
[22]
|
Fiorucci, S., Antonelli, E., Santucci, L., Morelli, O., Miglietti, M., Federici, B., Mannucci, R., Del Soldato, P. and Morelli, A. (1999) Gastrointestinal Safety of Nitric Oxide-Derived Aspirin Is Related to Inhibition of ICE-Like Cysteine Proteases in Rats. Gastroenterology, 116, 1089-1106. http://dx.doi.org/10.1016/S0016-5085(99)70012-0
|
[23]
|
Qiao, L., Hanif, R., Sphicas, E., Shiff, S.J. and Rigas, B. (1998) Effect of Aspirin on Induction of Apoptosis in HT-29 Human Colon Adenocarcinoma Cells. Biochemical Pharmacology, 55, 53-64. http://dx.doi.org/10.1016/S0006-2952(97)00400-0
|
[24]
|
Shiff, S.J., Koutsos, M.I., Qiao, L. and Rigas, B. (1996) Nonsteroidal Anti-Inflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and Apoptosis. Experimental Cell Research, 222, 179-188. http://dx.doi.org/10.1006/excr.1996.0023
|
[25]
|
Hanif, R., Feng, J., Shiff, S.J., Koutsos, M.I., Staiano-Coico, L. and Rigas, B. (1996) NSAIDs Inhibit the Growth of Colon Cancer Cells by a Prostaglandin-Independent Pathway. Biochemical Pharmacology, 52, 237-245. http://dx.doi.org/10.1016/0006-2952(96)00181-5
|
[26]
|
Rigas, B. and Shiff, S.J. (2000) Is an Effect on Cyclooxygenase Required for the Chemopreventive Effect of NSAIDs in Colon Cancer? A Model Reconciling the Current Contradiction. Medical Hypotheses, 54, 210-215. http://dx.doi.org/10.1054/mehy.1999.0023
|
[27]
|
Bakm, A.W., McKnight, W., Li, P., Del Soldato, P., Calignano, A., Cirino, G. and Wallace, J.L. (1998) Cyclooxygenase-Independent Chemoprevention with an Aspirin Derivative in a Rat Model of Colonic Adenocarcinoma. Life Sciences, 62, 367-373. http://dx.doi.org/10.1016/S0024-3205(98)00191-X
|
[28]
|
Garcia-Rodriguez, L.A. and Huerta-Alvarez, C. (2001) Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs. Epidemiology, 12, 88-93. http://dx.doi.org/10.1097/00001648-200101000-00015
|
[29]
|
Rosenberg, L., Palmer, J.R., Zauber, A.G., Warshauer, M.E., Stolley, P.D. and Shapiro, S. (1991) A Hypothesis: Nonsteroidal Anti-Inflammatory Drugs Reduce the Incidence of Large Bowel Cancer. Journal of the National Cancer Institute, 83, 355-358. http://dx.doi.org/10.1093/jnci/83.5.355
|
[30]
|
Rosenberg, L., Louik, C. and Shapiro, S. (1998) Nonsteroidal Anti-Inflammatory Drug Use and Reduced Risk of Large Bowel Carcinoma. Cancer, 82, 2326-2333. http://dx.doi.org/10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q
|
[31]
|
Giovannucci, E., Rim, E.B., Stampfer, M.J., Colditz, G.A., Ascherio, A. and Willett, W.C. (1994) Aspirin Use and the Risk of Colorectal Cancer and Adenoma in Male Health Professionals. Annals of Internal Medicine, 121, 241-246. http://dx.doi.org/10.7326/0003-4819-121-4-199408150-00001
|
[32]
|
Giovannucci, E., Egan, K., Hunter, D.J., Stampfer, M.J., Colditz, G.A., Ascherio, A., Willett, W.C. and Speizer, F.E. (1995) Aspirin and the Risk of Colorectal Cancer in Women. The New England Journal of Medicine, 333, 609-614. http://dx.doi.org/10.1056/NEJM199509073331001
|
[33]
|
Berkel, H.J., Holcombe, R.F., Middlebrooks, M. and Kannan, K. (1996) Nonsteroidal Anti-Inflammatory Drugs and Colorectal Cancer. Epidemiologic Reviews, 18, 205-217. http://dx.doi.org/10.1093/oxfordjournals.epirev.a017926
|
[34]
|
Thun, M.J., Namboodiri, M.M. and Heath Jr., C.W. (1991) Aspirin Use and Reduced Risk of Fatal Colon Cancer. The New England Journal of Medicine, 325, 1593-1596. http://dx.doi.org/10.1056/NEJM199112053252301
|
[35]
|
Muscat, J.E., Stellman, S.D. and Wynder, E.L. (1994) Nonsteroidal Anti-Inflammatory Drugs and Colorectal Cancer. Cancer, 74, 1847-1854.
|
[36]
|
Pollard, M. and Luckert, P.H. (1980) Indomethacin Treatment of Rats with Dimethylhydrazine-Induced Intestinal Tumors. Cancer Treatment Reviews, 64, 1323-1327.
|
[37]
|
Pollard, M. and Luckert, P.H. (1984) Effect of Piroxicam on Primary Intestinal Tumors Induced in Rats by N-Methylnitrosourea. Cancer Letters, 25, 117-121. http://dx.doi.org/10.1016/S0304-3835(84)80035-X
|
[38]
|
Metzger, U., Meier, J., Uhlshmid, G. and Weihe, H. (1984) Influence of Various Prostaglandin Synthesis Inhibitors on DMH-Induced Rat Colon Cancer. Diseases of the Colon & Rectum, 27, 366-369. http://dx.doi.org/10.1007/BF02553001
|
[39]
|
Reddy, B.S., Maruyama, H. and Kelloff, G. (1987) Dose-Related Inhibition of Dietary Piroxicam, a Nonsteroidal Anti-Inflammatory Drug, during Different Stages of Rat Colon Tumor Development. Cancer Research, 47, 5340-5346.
|
[40]
|
Reddy, B.S., Nayini, J., Tokumo, K., Rigotty, J., Zang, E. and Kelloff, G. (1990) Chemoprevention of Colon Carcinogenesis by Concurrent Administration of Piroxicam, a Nonsteroidal Anti-Inflammatory Drug with D,L-a-diftuoromethylor-nithine, an Ornithine Decarboxylase Inhibitor, in Diet. Cancer Research, 50, 2562-2568.
|
[41]
|
Rubio, C.A. (1984) Antitumoral Activity of Indomethacin on Experimental Esophageal Tumors. Journal of the National Cancer Institute, 72, 705-707.
|
[42]
|
Takahashi, M., Furukawa, F., Toyoda, K., Sato, H., Hasegawa, R., Imaida, K. and Hayashi, Y. (1990) Effects of Various Prostaglandin Synthesis Inhibitors on Pancreatic carcinogenesis in Hamsters after Initiation with N-Nitrosobis(2-oxopropyl)amine. Carcinogenesis, 11, 393-395. http://dx.doi.org/10.1093/carcin/11.3.393
|
[43]
|
Tanaka, T., Kojima, T., Okumura, A., Sugie, S. and Mori, H. (1993) Inhibitory Effect of the Non-Steroidal Anti-Inflammatory Drugs, Indomethacin and Piroxicam on 2-Acetylaminofluorene-Induced Hepatocarcinogenesis in Male ACI/N Rats. Cancer Letters, 68, 111-118. http://dx.doi.org/10.1016/0304-3835(93)90136-W
|
[44]
|
Jalbert, G. and Castonguay, A. (1992) Effects of NSAIDs on NNK-Induced Pulmonary and Gastric Tumorigenesis in A/J Mice. Cancer Letters, 66, 21-28. http://dx.doi.org/10.1016/0304-3835(92)90275-Z
|
[45]
|
Thun, M.S., Namboodiri, M.M., Calle, E.E., Flanders, M.D. and Heath Jr., C.W. (1993) Aspirin Use and Risk of Fatal Cancer. Cancer Letters, 53, 1322-1327.
|
[46]
|
Gridley, G., McLaughlin, J.K., Ekbom, A., Klareskog, L., Adami, H.O., Hacker, D.G., Hoover, R. and Fraumeni, J.F. (1993) Incidence of Cancer among Patients with Rheumatoid Arthritis. Journal of the National Cancer Institute, 85, 307-311. http://dx.doi.org/10.1093/jnci/85.4.307
|
[47]
|
Funkhouser, E.M. and Sharp, G.B. (1995) Aspirin and Reduced Risk of Esophageal Carcinoma. Cancer, 76, 1116-1119. http://dx.doi.org/10.1002/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I
|
[48]
|
Farrow, D.C., Vaughan, T.L., Hansten, P.D., Stanford, J.L., Risch, H.A., Gammon, M.D., Chow, W.H., Dubrow, R., Ahsan, H., Mayne, S.T., Schoenberg, J.B., West, A.B., Rotterdam, H., Fraumeni Jr., J.F. and Blot, W.J. (1998) Use of Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs and Risk of Esophageal and Gastric Cancer. Cancer Epidemiology, Biomarkers & Prevention, 7, 97-102.
|
[49]
|
Shapiro, S. (1982) Case-Control Surveillance. In: Strom, B.L., Ed., Pharmacoepidemiology, 2nd Edition, John Wiley and Sons, Chichester, 301-322.
|
[50]
|
Schreinemachers, D.M. and Everson, R.B. (1994) Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study. Epidemiology, 5, 138-146.
|
[51]
|
World Health Organization (2012) World Health Statistics 2012. http://www.who.int/gho/publications/world_health_statistics/2012/en/
|
[52]
|
Flegal, K.M., Carroll, M.D., Kit, B.K. and Ogden, C.L. (2012) Prevalence of Obesity and Trends in the Distribution of Body Mass Index among US Adults, 1999-2010. The Journal of the American Medical Association, 307, 491-497. http://dx.doi.org/10.1001/jama.2012.39
|
[53]
|
Calle, E.E., Rodriguez, C., Walker-Thurmond, K. and Thun, M.J. (2003) Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of US Adults. The New England Journal of Medicine, 348, 1625-1638. http://dx.doi.org/10.1056/NEJMoa021423
|